The observations made in these earlier studies have advanced considerably with the recognition that β2AR ligands modulate the transcription of the α-synuclein gene (SNCA) and that the gene product α-synuclein (α-syn) is implicated in the development of PD [1,5]. The gene discussed is SNCA; the disease is Parkinson disease.